Literature DB >> 304778

T and B lymphocytes in patients with chronic active hepatitis (CAH).

M Colombo, S J Vernace, F Paronetto.   

Abstract

Absolute numbers of T and B lymphocytes as well as active E rosette-forming cells were measured in twenty-seven patients with chronic active hepatitis (CAH), and in thirty control patients. In patients with CAH without cirrhosis, active E rosette-forming cells (a subpopulation of T lymphocytes considered to be actively involved in cell-mediated immune reactions) as well as lymphocytes with surface markers for IgA, IgM and IgG were increased. In patients with CAH and cirrhosis, total T lymphocytes were decreased. These results emphasize the significance of lymphocytes in CAH, and suggest the importance of monitoring T- and B-cell populations in patients with this disease.

Entities:  

Mesh:

Year:  1977        PMID: 304778      PMCID: PMC1541167     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  32 in total

1.  Local formation of gamma-globulin in the diseased liver, and its relation to hepatic necrosis.

Authors:  F PARONETTO; E RUBIN; H POPPER
Journal:  Lab Invest       Date:  1962-02       Impact factor: 5.662

2.  Depression of cell-mediated immunity in old age and the immunopathic diseases, lupus erythematosus, chronic hepatitis and rheumatoid arthritis.

Authors:  B H Toh; I C Roberts-Thomson; J D Mathews; S Whittingham; I R Mackay
Journal:  Clin Exp Immunol       Date:  1973-06       Impact factor: 4.330

3.  Cell-mediated immune reactivity in liver disease.

Authors:  P A Bacon; H Berry; R Bown
Journal:  Gut       Date:  1972-06       Impact factor: 23.059

4.  Letter: "Per cent T cells".

Authors:  B S Rabin; T L Whiteside
Journal:  Lancet       Date:  1974-07-06       Impact factor: 79.321

Review 5.  Cooperating and controlling functions of thymus-derived lymphocytes in relation to autoimmunity.

Authors:  A C Allison; A M Denman; R D Barnes
Journal:  Lancet       Date:  1971-07-17       Impact factor: 79.321

6.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

7.  Editorial: How clinically useful is T and B cell quantitation?

Authors:  J Wybran; H Fudenberg
Journal:  Ann Intern Med       Date:  1974-06       Impact factor: 25.391

8.  Immunological studies in patients with chronic active hepatitis. Cytotoxic activity of lymphocytes to autochthonous liver cells grown in tissue culture.

Authors:  F Paronetto; S Vernace
Journal:  Clin Exp Immunol       Date:  1975-01       Impact factor: 4.330

9.  Cell-mediated immunity to a human liver-specific antigen in patients with active chronic hepatitis and primary biliary cirrhosis.

Authors:  J Miller; M G Smith; C G Mitchell; W D Reed; A L Eddleston; R Williams
Journal:  Lancet       Date:  1972-08-12       Impact factor: 79.321

10.  Surface markers on human T and B lymphocytes. I. A large population of lymphocytes forming nonimmune rosettes with sheep red blood cells.

Authors:  M Jondal; G Holm; H Wigzell
Journal:  J Exp Med       Date:  1972-08-01       Impact factor: 14.307

View more
  10 in total

1.  Lymphocyte subpopulations in chronic liver disease.

Authors:  I G McFarlane; A L Eddleston; R Williams
Journal:  Clin Exp Immunol       Date:  1977-10       Impact factor: 4.330

2.  Active E rosette-forming cells in the peripheral blood of patients with chronic active hepatitis.

Authors:  M C de Moura; F Ramalho
Journal:  Dig Dis Sci       Date:  1979-07       Impact factor: 3.199

3.  Decreased suppressor T cell activity in patients with hepatic cirrhosis (HC).

Authors:  S Tomino; H Fujiwara; T Kagimoto; H Mitsuya; H Nishimura; S Kishimoto
Journal:  Clin Exp Immunol       Date:  1982-06       Impact factor: 4.330

4.  Disordered immunoregulatory functions in patients with chronic active hepatitis.

Authors:  A Nonomura; M Tanino; H Kurumaya; G Ohta; Y Kato; K Kobayashi
Journal:  Clin Exp Immunol       Date:  1982-03       Impact factor: 4.330

5.  Diminished active T rosette levels and increased spontaneous B lymphocyte blastogenesis in hepatitis B virus positive chronic active hepatitis.

Authors:  G Budillon; G Scala; C D'Onofrio; S Cassano; F De Ritis
Journal:  Clin Exp Immunol       Date:  1983-06       Impact factor: 4.330

6.  Immunological evaluation of asymptomatic carriers of hepatitis B virus.

Authors:  Y Levo; D Shouval; R Tur-Kaspa; S Wollner; S Penchas; A Zlotnick; M Eliakim
Journal:  Clin Exp Immunol       Date:  1981-04       Impact factor: 4.330

7.  In vitro synthesis of IgG by peripheral blood lymphocytes in chronic liver disease.

Authors:  M G Mutchnick; H M Lederman; A Missirian; A G Johnson
Journal:  Clin Exp Immunol       Date:  1981-02       Impact factor: 4.330

Review 8.  Immunologic effector mechanisms in hepatitis B-negative chronic active hepatitis.

Authors:  R J Klingenstein; J R Wands
Journal:  Springer Semin Immunopathol       Date:  1980-12

9.  T cell subsets in chronic hepatitis B and the effect of prednisolone withdrawal and interferon alpha-2b.

Authors:  E H Im; B S Lee; J K Sung; S O Lee; K T Lee; S M Lee; S H Kim; K S Seo; J H Kim; S G Kim; N J Kim; H Y Lee
Journal:  Korean J Intern Med       Date:  1999-01       Impact factor: 2.884

Review 10.  The immunopathogenesis of chronic HBV induced liver disease.

Authors:  G A Levy; F V Chisari
Journal:  Springer Semin Immunopathol       Date:  1981-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.